Evidence map›Paper›PMID 24423335›Full record

ArticleThe Journal of clinical endocrinology and metabolism2014

Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial.

Adana A Llanos, Juan Peng, Michael L Pennell, Jessica L Krok, Mara Z Vitolins, Cecilia R Degraffinreid, Electra D Paskett

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Adana A LlanosDivision of Population Sciences (A.A.L., J.L.K., C.R.D., E.D.P.), and Divisions of Biostatistics (J.P., M.L.P.) and Epidemiology (E.D.P.), College of Public Health, and Division of Cancer Prevention and Control (E.D.P.), College of Medicine, Ohio State University Comprehensive Cancer Center, The Ohio State University Columbus, Ohio 43210; Department of Epidemiology (A.A.L.), School of Public Health, Rutgers University, Piscataway, New Jersey 08854; Rutgers Cancer Institute of New Jersey (A.A.L.), New Brunswick, New Jersey 08903; and Department of Public Health Sciences (M.Z.V.), Wake Forest School of Medicine, Winston-Salem, North Carolina 27157.
Juan Peng
Michael L Pennell
Jessica L Krok
Mara Z Vitolins
Cecilia R Degraffinreid
Electra D Paskett
Ohio Department of Health · USRutgers Cancer Institute of New JerseyWake Forest University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
NCATS NIH HHS UL1 TR001070NCI NIH HHS P30 CA016058NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1-RR025755
6 · The paper itself

Abstract

contextBreast cancer risk among postmenopausal women increases as body mass index increases. Practical preventive methods to reduce risk of breast cancer are lacking. Few studies have investigated the effects of carotenoids and isoflavones on circulating adipokines in postmenopausal women.

objectiveThe aim was to examine the effects of lycopene- and isoflavone-rich diets on serum adipokines.

designThis was a 26-week, two-arm, longitudinal crossover trial.

settingParticipants were recruited from clinics at The Ohio State University Comprehensive Cancer Center.

participantsSeventy postmenopausal women at increased breast cancer risk participated in the study. The mean age and body mass index of participants was 57.2 years and 30.0 kg/m(2), respectively; the study was comprised of 81.4% whites.

interventionsThe interventions included 10 weeks of consumption of a tomato-based diet (≥25 mg lycopene daily) and 10 weeks of consumption of a soy-based diet (≥40 g of soy protein daily), with a 2-week washout in between.

main outcome measuresChanges in serum adiponectin, leptin, and the adiponectin to leptin ratio were examined for each intervention through linear mixed models, with ratio estimates corresponding to postintervention adipokine concentrations relative to preintervention concentrations.

resultsAfter the tomato intervention, among all women, adiponectin concentration increased (ratio 1.09, 95% confidence interval (CI) 1.00-1.18), with a stronger effect observed among nonobese women (ratio 1.13, 95% CI 1.02-1.25). After the soy intervention, adiponectin decreased overall (ratio 0.91, 95% CI 0.84-0.97), with a larger reduction observed among nonobese women (ratio 0.89, 95% CI 0.81-0.98). Overall, no significant changes in leptin or the adiponectin to leptin ratio were observed after either intervention.

conclusionsIncreasing dietary consumption of tomato-based foods may beneficially increase serum adiponectin concentrations among postmenopausal women at increased breast cancer risk, especially those who are not obese. Additional studies are essential to confirm these effects and to elucidate the specific mechanisms that may make phytonutrients found in tomatoes practical as breast cancer chemopreventive agents.

Indexed as

Solanum lycopersicumSoybean ProteinsAdiponectinAdultAgedBody Mass IndexBreast NeoplasmsCross-Over StudiesDietFemaleHumansLeptinMiddle AgedPostmenopauseRiskAdiponectinLeptinSoybean Proteins

Identifiers

PMID24423335
PMCPMC3913803
OpenAlexW1968704213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.